1 result
  • Dapa-HF

    Evaluation of the effect of dapagilifiozin on the incidence of worsening heart failure or cardiovascular death in patients with chronic heart failure with reduced ejection fraction.

    Type: Drug trial

    Principal Investigator: John B. Kostis, MD

    Trial is open for enrollment

    For inquiries, call (732) 235-6546
    • Rutgers Robert Wood Johnson Medical School
    • Robert Wood Johnson University Hospital